Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology

Molecular Oncology

Volumn 4, Issue 6, 2010, Pages 496-510

  Karagiannis, George S ^a,b   Pavlou, Maria P ^a,b   Diamandis, Eleftherios P ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cancer; Mass spectrometry; Proteomics; Secretome

Indexed keywords

CHEMOKINE; GROWTH FACTOR; PROTEINASE; TUMOR MARKER;

ADIPOCYTE; ANGIOGENESIS; AUTOCRINE EFFECT; BIOINFORMATICS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER THERAPY; ENDOTHELIUM CELL; EXOSOME; FIBROBLAST; HOST CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; MELANOMA; METASTASIS; NEOPLASM; NONHUMAN; ONCOLOGY; PARACRINE SIGNALING; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEOMICS; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 78349311747     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.09.001     Document Type: Review

References (124)

1. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422(6928):198-207.
2. Bendtsen J.D., Jensen L.J., et al. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des Sel 2004, 17(4):349-356.
3. Bendtsen J.D., Nielsen H., et al. Improved prediction of signal peptides: signalP 3.0. J. Mol. Biol. 2004, 340(4):783-795.
4. 2 availability on human cancer. Nat. Rev. Cancer 2008, 8(12):967-975.
5. Bialkowska K., Zaffran Y., et al. 14-3-3 zeta mediates integrin-induced activation of Cdc42 and Rac. Platelet glycoprotein Ib-IX regulates integrin-induced signaling by sequestering 14-3-3 zeta. J. Biol. Chem. 2003, 278(35):33342-33350.
6. Birkenfeld J., Betz H., et al. Identification of cofilin and LIM-domain-containing protein kinase 1 as novel interaction partners of 14-3-3 zeta. Biochem. J. 2003, 369(Pt 1):45-54.
7. Blum G., von Degenfeld G., et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat. Chem. Biol. 2007, 3(10):668-677.
8. Boraldi F., Annovi G., et al. Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach. Biochim. Biophys. Acta 2007, 1774(11):1402-1413.
9. Borgono C.A., Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 2004, 4(11):876-890.
10. Cancemi P., Albanese N.N., et al. Multiple changes induced by fibroblasts on breast cancer cells. Connect. Tissue Res. 2009, 51(2):88-104.
11. Cao J., Hu Y., et al. Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells. Proteomics 2009, 9(21):4881-4888.
12. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6(4):389-395.
13. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407(6801):249-257.
14. Celis A., Rasmussen H.H., et al. Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis 1999, 20(2):355-361.
15. Celis J.E., Moreira J.M., et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell Proteomics 2005, 4(4):492-522.
16. Chang Y.H., Wu C.C., et al. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. J. Proteome Res. 2009, 8(12):5465-5474.
17. Chung S.D., Yu H.J., et al. Re: Ching-Chia Li, Tu-Hao Chang, Wen-Jeng Wu, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in taiwanese patients. Eur. Urol. 2009, 2008(54):1127-1135. Eur Urol 55(4): e69-70; author reply e71.
18. Ciborowski P., Kadiu I., et al. Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 2007, 363(1):198-209.
19. Colzani M., Waridel P., et al. Metabolic labeling and protein linearization technology allow the study of proteins secreted by cultured cells in serum-containing media. J. Proteome Res. 2009, 8(10):4779-4788.
20. Conn E.M., Madsen M.A., et al. Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation. J. Biol. Chem. 2008, 283(39):26518-26527.
21. Cooper S. Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points. Faseb J. 2003, 17(3):333-340.
22. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867.
23. De Wever O., Nguyen Q.D., et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. Faseb J. 2004, 18(9):1016-1018.
24. Dean R.A., Overall C.M. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol. Cell Proteomics 2007, 6(4):611-623.
25. Delany A.M., Canalis E. Dual regulation of stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts. J. Biol. Chem. 1998, 273(26):16595-16600.
26. Denny P.W., Gokool S., et al. Acylation-dependent protein export in Leishmania. J. Biol. Chem. 2000, 275(15):11017-11025.
27. Doucet A., Butler G.S., et al. Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Mol. Cell Proteomics 2008, 7(10):1925-1951.
28. Eck S.M., Cote A.L., et al. CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells. Mol. Cancer Res. 2009, 7(7):1033-1044.
29. Emami N., Diamandis E.P. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers. Clin. Chem. 2008, 54(10):1600-1607.
30. Everley P.A., Zetter B.R. Proteomics in tumor progression and metastasis. Ann. N. Y Acad. Sci. 2005, 1059:1-10.
31. Ferrara N., Gerber H.P., et al. The biology of VEGF and its receptors. Nat. Med. 2003, 9(6):669-676.
32. Finley D.S., Calvert V.S., et al. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J. Urol. 2009, 182(4):1621-1627.
33. Geho D.H., Bandle R.W., et al. Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda) 2005, 20:194-200.
34. Gromov P., Gromova I., et al. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol. Oncol. 2010, 4(1):65-89.
35. Grothey A., Galanis E. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat. Rev. Clin. Oncol. 2009, 6(9):507-518.
36. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
37. Hasan N.M., Adams G.E., et al. Effect of serum starvation on expression and phosphorylation of PKC-alpha and p53 in V79 cells: implications for cell death. Int. J. Cancer 1999, 80(3):400-405.
38. Hegmans J.P., Bard M.P., et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol. 2004, 164(5):1807-1815.
39. Hill J.J., Moreno M.J., et al. Identification of secreted proteins regulated by cAMP in glioblastoma cells using glycopeptide capture and label-free quantification. Proteomics 2009, 9(3):535-549.
40. Hood J.L., Pan H., et al. Paracrine induction of endothelium by tumor exosomes. Lab. Invest. 2009, 89(11):1317-1328.
41. Iannetti A., Pacifico F., et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl. Acad. Sci. U S A 2008, 105(37):14058-14063.
42. Ivy S.P., Wick J.Y., et al. An overview of small-molecule inhibitors of VEGFR signaling. Nat. Rev. Clin. Oncol. 2009, 6(10):569-579.
43. Jain K.K. Innovations, challenges and future prospects of oncoproteomics. Mol. Oncol. 2008, 2(2):153-160.
44. Ji H., Erfani N., et al. Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes. Electrophoresis 2008, 29(12):2660-2671.
45. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9(4):239-252.
46. Jung T., Castellana D., et al. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 2009, 11(10):1093-1105.
47. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6(5):392-401.
48. Kim J.H., Kim K.Y., et al. Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells. Cancer Lett. 2008, 261(2):253-262.
49. Kim K.Y., Baek A., et al. Adipocyte culture medium stimulates invasiveness of MDA-MB-231 cell via CCL20 production. Oncol. Rep. 2009, 22(6):1497-1504.
50. Klee E.W., Ellis L.B. Evaluating eukaryotic secreted protein prediction. BMC Bioinform. 2005, 6:256.
51. Kobayashi R., Deavers M., et al. 14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients. Cancer Immunol. Immunother 2009, 58(2):247-258.
52. Koga K., Matsumoto K., et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005, 25(6A):3703-3707.
53. Koperek O., Scheuba C., et al. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int. J. Oncol. 2007, 31(1):59-67.
54. Kulasingam V., Diamandis E.P. Tissue culture-based breast cancer biomarker discovery platform. Int. J. Cancer 2008, 123(9):2007-2012.
55. Kunz-Schughart L.A., Knuechel R. Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression?. Histol. Histopathol 2002, 17(2):599-621.
56. Levin V.A., Panchabhai S.C., et al. Different changes in protein and phosphoprotein levels result from serum starvation of high-grade glioma and adenocarcinoma cell lines. J. Proteome Res. 2010, 9(1):179-191.
57. Lewis M.P., Lygoe K.A., et al. Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer 2004, 90(4):822-832.
58. Li M.X., Xiao Z.Q., et al. Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue. J. Cell Biochem. 2009, 106(4):570-579.
59. Liang X., Huuskonen J., et al. Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines. Proteomics 2009, 9(1):182-193.
60. Liang X., Zhao J., et al. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma. J. Proteome Res. 2006, 5(10):2632-2641.
61. Liu Y., Patricelli M.P., et al. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(26):14694-14699.
62. Marconi C., Bianchini F., et al. Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells. Clin. Exp. Metastasis 2008, 25(3):225-231.
63. Mareel M., Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 2003, 83(2):337-376.
64. Mathias R.A., Chen Y.S., et al. Extracellular remodelling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration. J. Proteome Res. 2010, 9(2):1007-1019.
65. Mathias R.A., Wang B., et al. Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition. J. Proteome Res. 2009, 8(6):2827-2837.
66. Mathivanan S., Ahmed M., et al. Human Proteinpedia enables sharing of human protein data. Nat. Biotechnol. 2008, 26(2):164-167.
67. Mathivanan S., Lim J.W., et al. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell Proteomics 2009, 9(2):197-208.
68. Mathivanan S., Simpson R.J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009, 9(21):4997-5000.
69. Mears R., Craven R.A., et al. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004, 4(12):4019-4031.
70. Mellman I., Warren G. The road taken: past and future foundations of membrane traffic. Cell 2000, 100(1):99-112.
71. Mignatti P., Morimoto T., et al. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell Physiol. 1992, 151(1):81-93.
72. Moller S., Croning M.D., et al. Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 2001, 17(7):646-653.
73. Mueller L., Goumas F.A., et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am. J. Pathol. 2007, 171(5):1608-1618.
74. Mueller M.M., Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004, 4(11):839-849.
75. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 2003, 270(10):2109-2119.
76. Ochieng J., Pratap S., et al. Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes. Exp. Cell Res. 2009, 315(11):1875-1888.
77. Orimo A., Tomioka Y., et al. Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin. Cancer Res. 2001, 7(10):3097-3105.
78. Ornstein D.K., Gillespie J.W., et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 2000, 21(11):2235-2242.
79. Overall C.M., Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 2006, 6(3):227-239.
80. Pages F., Galon J., et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010, 29(8):1093-1102.
81. Park J.E., Tan H.S., et al. Hypoxia modulates tumor microenvironment to enhance angiogenic and metastastic potential by secretion of proteins and exosomes. Mol Cell Proteomics 2010.
82. Park S., Cheon S., et al. The dual effects of interleukin-18 in tumor progression. Cell Mol. Immunol. 2007, 4(5):329-335.
83. Paschos K.A., Canovas D., et al. The engagement of selectins and their ligands in colorectal cancer liver metastases. J. Cell Mol. Med. 2009.
84. Paschos K.A., Canovas D., et al. The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal. 2009, 21(5):665-674.
85. Paulitschke V., Kunstfeld R., et al. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells. J. Proteome Res. 2009, 8(5):2501-2510.
86. Pavlides S., Whitaker-Menezes D., et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009, 8(23):3984-4001.
87. Pinto A.F., Ma L., et al. Use of SILAC for exploring sheddase and matrix degradation of fibroblasts in culture by the PIII SVMP atrolysin A: identification of two novel substrates with functional relevance. Arch. Biochem. Biophys. 2007, 465(1):11-15.
88. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 2003, 9(6):677-684.
89. Qu J.L., Qu X.J., et al. The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells. Acta Oncol. 2009, 48(8):1173-1180.
90. Qu J.L., Qu X.J., et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig. Liver Dis. 2009, 41(12):875-880.
91. Rhee S.Y., Wood V., et al. Use and misuse of the gene ontology annotations. Nat. Rev. Genet. 2008, 9(7):509-515.
92. Rho J.H., Roehrl M.H., et al. Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J. Proteome Res. 2009, 8(12):5610-5618.
93. Rondepierre F., Bouchon B., et al. B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator. Melanoma Res. 2009, 20(2):77-84.
94. Rubartelli A., Cozzolino F., et al. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. Embo J. 1990, 9(5):1503-1510.
95. Saad S., Gottlieb D.J., et al. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res. 2002, 62(1):283-289.
96. Saghatelian A., Jessani N., et al. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(27):10000-10005.
97. Schmidinger H., Hermetter A., et al. Activity-based proteomics: enzymatic activity profiling in complex proteomes. Amino Acids 2006, 30(4):333-350.
98. Schnabele K., Roser S., et al. Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells. Eur. J. Nutr. 2009, 48(3):154-161.
99. Schoppmann S.F., Birner P., et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 2002, 161(3):947-956.
100. Shi H.J., Stubbs R., et al. Characterization of de novo synthesized proteins released from human colorectal tumour explants. Electrophoresis 2009, 30(14):2442-2453.
101. Shin J.S., Hong S.W., et al. Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells. Int. J. Oncol. 2008, 32(2):435-439.
102. Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6(10):813-823.
103. Sierra J.R., Corso S., et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J. Exp. Med. 2008, 205(7):1673-1685.
104. Simpson R.J., Jensen S.S., et al. Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8(19):4083-4099.
105. Singer C.F., Kronsteiner N., et al. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res. Treat. 2002, 72(1):69-77.
106. Slany A., Haudek V.J., et al. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. J. Proteome Res. 2010, 9(1):6-21.
107. Srisomsap C., Sawangareetrakul P., et al. Proteomic analysis of cholangiocarcinoma cell line. Proteomics 2004, 4(4):1135-1144.
108. Tam E.M., Morrison C.J., et al. Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(18):6917-6922.
109. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15(6):740-746.
110. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7(2):131-142.
111. Tjalsma H., Bolhuis A., et al. Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol. Mol. Biol. Rev. 2000, 64(3):515-547.
112. Trudel C., Faure-Desire V., et al. Translocation of FGF2 to the cell surface without release into conditioned media. J. Cell Physiol. 2000, 185(2):260-268.
113. Tsukinoki K., Yasuda M., et al. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma. Oncol. Rep. 2004, 12(5):1017-1021.
114. Vajkoczy P., Knyazev P., et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(15):5799-5804.
115. Van Der Hoeven P.C., Van Der Wal J.C., et al. Protein kinase C activation by acidic proteins including 14-3-3. Biochem. J. 2000, 347(Pt 3):781-785.
116. Walter P., Gilmore R., et al. Protein translocation across the endoplasmic reticulum. Cell 1984, 38(1):5-8.
117. Weng L.P., Wu C.C., et al. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J. Proteome Res. 2008, 7(9):3765-3775.
118. Xiao Z., Blonder J., et al. Proteomic analysis of extracellular matrix and vesicles. J. Proteomics 2009, 72(1):34-45.
119. Xing F., Saidou J., et al. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front. Biosci. 2010, 15:166-179.
120. Xue H., Lu B., et al. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J. Proteome Res. 2010, 9(1):545-555.
121. Yilmaz M., Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009, 28(1-2):15-33.
122. Zander L., Bemark M. Identification of genes deregulated during serum-free medium adaptation of a Burkitt's lymphoma cell line. Cell Prolif. 2008, 41(1):136-155.
123. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119(6):1429-1437.
124. Zhong L., Roybal J., et al. Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res. 2008, 68(17):7237-7245.